IL17A and psoriasis: The central importance of IL-17 to the development and maintenance of disease has been confirmed with the clinical effectiveness of IL-17/IL-17 receptor neutralizing antibodies in psoriasis patients [4,5], where systemic treatment with these biologics normalizes inflammatory gene expression [6,7].